MedPath

Evaluation test for oral cavity

Not Applicable
Conditions
Healthy adults
Registration Number
JPRN-UMIN000044482
Lead Sponsor
Kao Corporation
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

-Subjects with systemic illness. -Subjects with a disease in the oral cavity and are consulting the medical institution. -Subjects with periodontal disease is treated. -Subjects with the orthodontic therapy. -Subjects with mobile tooth. -Subjects with an implant. -Subjects who have regular dental checkups at least three times a year. -Subjects who have been prescribed antibiotics for swollen gingival within a year. -The pregnant and subjects who hope to get pregnant during the exam period. -Subjects who are taking prescription medicine (except for anti-hay fever). -Subjects from outside the company who work in an advertising agency, an investigation, consultancy, mass communication, and the manufacturing industry of health food, cosmetics, toiletries, a sanitary items, and a distributive trade. -Subjects who participate in the other examinations. -Subjects who had health problems (fever, cold-like symptom, abnormal taste or smell, etc.) within 2 weeks prior to the test, or subjects who had a family member living with them who showed abnormalities. -Subjects who had close contact with COVID-19 infected individuals within 2 weeks prior to the study. -Subjects who are confirmed positive in the COVID-19 antigen test on the day of measurement. -Subjects deemed inappropriate to participate in this study by the principle investigator.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Measurement of oral index. Measurements are taken 3 times, before starting test, after using composion 210515 for 12 weeks and 24 weeks.
Secondary Outcome Measures
NameTimeMethod
Taking photography of oral cavity and questionnaire. Each measurement are taken 3 times, before starting test, after using composite210515 for 12 weeks and 24 weeks.
© Copyright 2025. All Rights Reserved by MedPath